Home Newsfeeds Barrington Research Maintains Outperform on Carriage Servs, Lowers Price Target to $40

Barrington Research Maintains Outperform on Carriage Servs, Lowers Price Target to $40

Barrington Research analyst Alexander Paris maintains Carriage Servs (NYSE:CSV) with a Outperform and lowers the price target from $50 to $40.

byBenzinga Newsdesk

October 27, 2022

1 minute read

Barrington Research analyst Alexander Paris maintains Carriage Servs (NYSE:CSV) with a Outperform and lowers the price target from $50 to $40.

Wave Life Sciences Shares Move Higher On Therapeutic Pact With GSK Targeting Genetic Disorders

By Vandana Singh

December 13, 10:51 AM

Wave Life Sciences Ltd (NASDAQ:WVE) and GSK plc (NYSE:GSK) have announced a strategic collaboration to advance oligonucleotide therapeutics, including Wave’s preclinical RNA editing…

GSK

News

NICE Actimize Launches Compliancentral, An End-To-End Communications And Trade Compliance Platform

By Benzinga Newsdesk

September 20, 8:43 AM

The new cloud-based platform empowers firms to know more and risk less by capturing and surveilling complete communication, trade and behavioral data to reveal hidden conduct risk NICE Actimize,

NICE

Microbot Medical Initiates Preparations For First-In-Human Cases In Brazil For The LIBERTY Robotic System

By Happy Mohamed

May 8, 8:42 AM

Microbot Medical Inc. (NASDAQ:MBOT), the developer of the LIBERTY Robotic system, the first fully disposable endovascular robotic system, announced that it has initiated preparations for potential First-In-Human cases in

MBOT

Crude Oil Rises Over 1%; Fed’s Preferred Inflation Gauge Slows In May

By Lisa Levin

June 30, 12:01 PM

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up 0.62% to 34,333.42 while the NASDAQ rose 1.37% to 13,777.52. The S&P 500, also rose, gaining, 1.04% to 4,441.95.

BXRX

Barrington Research Maintains Outperform on Carriage Servs, Lowers Price Target to $40

Related Posts

Wave Life Sciences Shares Move Higher On Therapeutic Pact With GSK Targeting Genetic Disorders

NICE Actimize Launches Compliancentral, An End-To-End Communications And Trade Compliance Platform

Microbot Medical Initiates Preparations For First-In-Human Cases In Brazil For The LIBERTY Robotic System

Crude Oil Rises Over 1%; Fed’s Preferred Inflation Gauge Slows In May